Remedium Bio
PrivateLast Round
Seed Round
May 18, 2026
Total Funding Raised
$20.72M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Remedium Bio is a biotechnology company that develops gene therapies for large unmet clinical needs using its proprietary Prometheus™ adjustable gene therapy platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Remedium Bio Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Remedium Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed Round | May 18, 2026 | ||||
| Series A | Sep 8, 2025 | ||||
| Grant | Sep 30, 2024 | ||||
| Grant | Sep 1, 2024 | ||||
| Grant | Nov 24, 2023 | ||||
Grant | Aug 1, 2023 |
Remedium Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Apis Health Angels | Seed |
| Wharton Alumni Angels | Grant |
| Longevitytech.fund | Seed |
| VitaDAO | Grant |
| Bill & Melinda Gates Foundation | Grant |
| The Bill & Melinda Gates Foundation Trust | Grant |
| Ulu Ventures | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 20, 2026
Monthly visitors grew 69% MoM, reaching 2.5K.
- May 18, 2026
$2M raised in Seed Round.
Remedium Bio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Remedium Bio's valuation, stock price, and market status.